Evaluation of AI Cost Prediction Model to Enroll Patients in Complex Care Management Program
NCT06916247
Chronic Disease, Disease Attributes
Los Angeles, California, United States
View Trial DetailsNCT Number: NCT03216161
This study was an update and amplification of exposure measurements of the EPIC-Potsdam Study, which started in 1994-1998.
Looking for future studies?
Notify Me35 year–64 year
All sexes
Observational
The sub-study was conducted in the German Institute of Human Nutrition according to an approved study protocol.
The study program included comprehensive surveys on diet and lifestyle (smoking, physical activity, and anthropometry). The aim was to achieve repeated measurements in a sub-cohort of about 600 people to validate (measurement error correction) and calibrate (adjustment of insufficient data collected to the actual data location) existing baseline data in the entire cohort (EPIC-Potsdam cohort).
To this end, within age groups and by gender, active EPIC participants were then randomly selected in the years 2009 to 2012 from the cohort, contacted and invited to re-visit the respective study center. 816 subjects were acquired for re-examination, participation rate was 56.4%.
Each participant gave informed consent. The study protocol has been approved by the Ethics Committee of the Medical Association of the State of Brandenburg, Cottbus, on 18/12/2009.
The information in this section are study hypothesis and contains no results or conclusions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 4-24 months
Repeated 24 hour dietary recalls. Every participant provided up to three (mean = 2.99) 24 hour dietary recalls at baseline (cross-sectional analysis). The recalls were performed by trained interviewers using EPIC-Soft program and were collected within a period of 4-24 months (mean = 7). The first recall took place in person during the participants' first visit to the study center. The following two recalls took place on random days over the telephone. Food consumption was recorded in 11 eating occasions (before breakfast, breakfast, after breakfast, during morning, lunch, after lunch, during the afternoon, before dinner, dinner, after dinner, during evening) and was recorded for each food in grams per eating occasion.
Time frame: Appointment at the study center at beginning of study
In kilograms. For the purpose of achieving improved and more detailed assessment of anthropometric measeures
Time frame: Appointment at the study center at beginning of study
In millimeters. For the purpose of achieving improved and more detailed assessment of anthropometric measeures
Time frame: Within 4 weeks after first visit to the study center
The measurements were performed with a 1.5T MRT scanner ("Magnetom Avanto", Siemens, Erlangen, Germany) and the Vibe Dixon sequence. The Vibe-Dixon sequence is a special MRT protocol fornbody fat analysis which separates the fat from tissue water. Fat tissue is displayed brightly, while the remaining tissue appears dark.
Time frame: Appointment at the study center at beginning of study
Height, circumference of hip and waist, depth and width of chest (all in centimeters). For the purpose of achieving improved and more detailed assessment of anthropometric measeures
Time frame: 1 week
A heart rate monitor and integrated accelerometer ("Actiheart" CamNtech, Cambridge, UK) was work for a week of everyday life. The Actiheart software calculated physical activity based on the individual calibration models in the form of "Physical Activity Levels", which is the ratio of the total energy expenditure for resting enery expenditure.
Time frame: 12 months (retrospective questionnaire)
Participants also filled in a questionnaire on physical activity (physical activity during the past 12 months and activities in the last 4 weeks).
German Institute of Human Nutrition
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06916247
Chronic Disease, Disease Attributes
Los Angeles, California, United States
View Trial DetailsNCT03195127
Chronic Disease, Critical Illness
Baltimore, Maryland, United States
View Trial DetailsNCT05574699
Cardiovascular Diseases, Chronic Disease
Baltimore, Maryland, United States
View Trial DetailsNCT04264897
Aging, Chronic Disease
Oklahoma City, Oklahoma, United States
View Trial Details